Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass spectrometry

被引:75
作者
Bodamer, OA
Bloesch, SM
Gregg, AR
Stockler-Ipsiroglu, S
O'Brien, WE
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Biochim Genet Lab, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Gynecol & Obstet, Houston, TX 77030 USA
[3] Univ Hosp Vienna, Dept Pediat, A-1090 Vienna, Austria
关键词
creatine; guanidinoacetate; guanidinoacetate methyltransferase; isotope dilution; neonatal screening;
D O I
10.1016/S0009-8981(01)00480-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Guanidinoacetate methyltransferase (GAMT) deficiency is a disorder of creatine metabolism characterized by low plasma creatine concentrations in combination with elevated guanidinoacetate (C;AA) concentrations. Although rare. GAMT deficiency has been identified in children with seizures, extrapyramidal movements, developmental delay, myopathies: and behavioral abnormalities. Treatment with creatine monohydrate has been proven to be effective. We describe an isotope dilution electrospray tandem mass spectrometry (ES-MS/MS) assay for the simultaneous determination of plasma GAA and creatine using multiple reaction monitoring (MRM), d(3)-creatine as the internal standard and derivatization of GAA and creatine as butyl-esters. We analysed plasma of 16 healthy adults and 20 healthy children as well as three affected children. Plasma GAA concentrations were 5.02 +/- 1.84 mu mol/l (mean +/- S.D.) in adults, 3.91 +/- 0.76 mu mol/l in children age 5-10 years and 11.57. 15.16. 14.36 mu mol/l in children with GAMT deficiency. Plasma creatine concentrations were 34.7 +/- 15.25 mu mol/l in adults, 58.96 +/- 22.30 mu mol/l in children and 5.37, 8.15. 403.5 mu mol/l in two untreated children and one treated child with GAMT deficiency, respectively. GAA can also be reliably measured from filter cards, which is sufficient to make: the correct diagnosis while creatine is consistently falsely elevated probably secondary to liberation of red cell creatine. In nine healthy newborn infants, GAA concentrations From Filter cards were 4.83 +/- 1.43 and 5.04 +/- 1.84 mu mol/l in 16 healthy adults. We conclude that isotope dilution ES-MS/MS is ideal for rapid high-throughput diagnosis of GAMT deficiency both from plasma and filter paper cards. Using this technique neonatal screening is feasible for this treatable inborn error of creatine metabolism. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 12 条
[1]   Guanidinoacetate methyltransferase deficiency: New clinical features [J].
Ganesan, V ;
Johnson, A ;
Connelly, A ;
Eckhardt, S ;
Surtees, RAH .
PEDIATRIC NEUROLOGY, 1997, 17 (02) :155-157
[2]   GC-MS determination of guanidinoacetate in urine and plasma [J].
Hunneman, DH ;
Hanefeld, F .
JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (03) :450-452
[3]   Guanidinoacetate methyltransferase (GAMT) deficiency:: non-invasive enzymatic diagnosis of a newly recognized inborn error of metabolism [J].
Ilas, J ;
Mühl, A ;
Stöckler-Ipsiroglu, S .
CLINICA CHIMICA ACTA, 2000, 290 (02) :179-188
[4]   GUANIDINO COMPOUNDS IN SERUM, URINE, LIVER, KIDNEY, AND BRAIN OF MAN AND SOME UREOTELIC ANIMALS [J].
MARESCAU, B ;
DESHMUKH, DR ;
KOCKX, M ;
POSSEMIERS, I ;
QURESHI, IA ;
WIECHERT, P ;
DEDEYN, PP .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (05) :526-532
[5]   Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: Diagnostic tools for a new inborn error of metabolism [J].
Schulze, A ;
Hess, T ;
Wevers, R ;
Mayatepek, E ;
Bachert, P ;
Marescau, B ;
Knopp, MV ;
DeDeyn, PP ;
Bremer, HJ ;
Rating, D .
JOURNAL OF PEDIATRICS, 1997, 131 (04) :626-631
[6]   Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis [J].
Stockler, S ;
Marescau, B ;
DeDeyn, PP ;
Trijbels, JMF ;
Hanefeld, F .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (10) :1189-1193
[7]  
Stockler S, 1996, AM J HUM GENET, V58, P914
[8]   An accurate stable isotope dilution gas chromatographic mass spectrometric approach to the diagnosis of guanidinoacetate methyltransferase deficiency [J].
Struys, EA ;
Jansen, EEW ;
ten Brink, HJ ;
Verhoeven, NM ;
van der Knaap, MS ;
Jakobs, C .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (4-5) :659-665
[9]  
Tuchman M, 1999, CLIN CHEM, V45, P571
[10]  
van der Knaap MS, 2000, ANN NEUROL, V47, P540, DOI 10.1002/1531-8249(200004)47:4<540::AID-ANA23>3.3.CO